A citation-based method for searching scientific literature

Albert Giralt, Ana Saavedra, Jordi Alberch, Esther Pérez-Navarro. J Huntingtons Dis 2012
Times Cited: 43







List of co-cited articles
841 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
A Giralt, M Puigdellívol, O Carretón, P Paoletti, J Valero, A Parra-Damas, C A Saura, J Alberch, S Ginés. Hum Mol Genet 2012
101
34

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
32

Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
Albert Giralt, Ana Saavedra, Olga Carretón, Xavier Xifró, Jordi Alberch, Esther Pérez-Navarro. Hum Mol Genet 2011
85
30


Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.
V C Wheeler, W Auerbach, J K White, J Srinidhi, A Auerbach, A Ryan, M P Duyao, V Vrbanac, M Weaver, J F Gusella,[...]. Hum Mol Genet 1999
279
25

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
25


Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
K P Murphy, R J Carter, L A Lione, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 2000
286
23

PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.
Albert Giralt, Ana Saavedra, Olga Carretón, Helena Arumí, Shiraz Tyebji, Jordi Alberch, Esther Pérez-Navarro. Hippocampus 2013
57
23


Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease.
Gary Lynch, Eniko A Kramar, Christopher S Rex, Yousheng Jia, Danielle Chappas, Christine M Gall, Danielle A Simmons. J Neurosci 2007
144
20

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.
H D Rosas, W J Koroshetz, Y I Chen, C Skeuse, M Vangel, M E Cudkowicz, K Caplan, K Marek, L J Seidman, N Makris,[...]. Neurology 2003
369
20

Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
Austen J Milnerwood, Damian M Cummings, Glenn M Dallérac, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Payam Rezaie, Kerry P S J Murphy. Hum Mol Genet 2006
112
18

Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.
Ana Saavedra, Albert Giralt, Helena Arumí, Jordi Alberch, Esther Pérez-Navarro. PLoS One 2013
47
18

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
253
18

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
18

Huntington's disease.
Francis O Walker. Lancet 2007
18

Role of brain-derived neurotrophic factor in Huntington's disease.
Chiara Zuccato, Elena Cattaneo. Prog Neurobiol 2007
386
18

Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
Carmela Giampà, Daunia Laurenti, Serenella Anzilotti, Giorgio Bernardi, Frank S Menniti, Francesca Romana Fusco. PLoS One 2010
138
16

Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.
Albert Giralt, Olga Carretón, Cristina Lao-Peregrin, Eduardo D Martín, Jordi Alberch. Mol Neurodegener 2011
76
16

Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
V Brito, M Puigdellívol, A Giralt, D del Toro, J Alberch, S Ginés. Cell Death Dis 2013
59
16

Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice.
Danielle A Simmons, Christopher S Rex, Linda Palmer, Vijay Pandyarajan, Vadim Fedulov, Christine M Gall, Gary Lynch. Proc Natl Acad Sci U S A 2009
183
16

Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
Tara L Spires, Helen E Grote, Sylvia Garry, Patricia M Cordery, Anton Van Dellen, Colin Blakemore, Anthony J Hannan. Eur J Neurosci 2004
139
16

Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Jeremy M Van Raamsdonk, Jacqueline Pearson, Elizabeth J Slow, Sazzad M Hossain, Blair R Leavitt, Michael R Hayden. J Neurosci 2005
229
16

Molecular mechanisms and potential therapeutical targets in Huntington's disease.
Chiara Zuccato, Marta Valenza, Elena Cattaneo. Physiol Rev 2010
560
16

Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.
Verónica Brito, Albert Giralt, Lilian Enriquez-Barreto, Mar Puigdellívol, Nuria Suelves, Alfonsa Zamora-Moratalla, Jesús J Ballesteros, Eduardo D Martín, Nuria Dominguez-Iturza, Miguel Morales,[...]. J Clin Invest 2014
66
16

Executive and mnemonic functions in early Huntington's disease.
A D Lawrence, B J Sahakian, J R Hodges, A E Rosser, K W Lange, T W Robbins. Brain 1996
283
16

Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection.
E Spargo, I P Everall, P L Lantos. J Neurol Neurosurg Psychiatry 1993
114
16

Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Andrés Miguez, Gerardo García-Díaz Barriga, Verónica Brito, Marco Straccia, Albert Giralt, Silvia Ginés, Josep M Canals, Jordi Alberch. Hum Mol Genet 2015
84
16

Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.
Sonia Marco, Albert Giralt, Milos M Petrovic, Mahmoud A Pouladi, Rebeca Martínez-Turrillas, José Martínez-Hernández, Linda S Kaltenbach, Jesús Torres-Peraza, Rona K Graham, Masahiko Watanabe,[...]. Nat Med 2013
77
13

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
J A Bibb, Z Yan, P Svenningsson, G L Snyder, V A Pieribone, A Horiuchi, A C Nairn, A Messer, P Greengard. Proc Natl Acad Sci U S A 2000
236
13

Impaired synaptic plasticity in mice carrying the Huntington's disease mutation.
M T Usdin, P F Shelbourne, R M Myers, D V Madison. Hum Mol Genet 1999
184
13

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
246
13

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
337
13

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
587
13

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
791
13

Brain imaging and cognitive dysfunctions in Huntington's disease.
Alonso Montoya, Bruce H Price, Matthew Menear, Martin Lepage. J Psychiatry Neurosci 2006
165
13

Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.
Ana Saavedra, Albert Giralt, Laura Rué, Xavier Xifró, Jian Xu, Zaira Ortega, José J Lucas, Paul J Lombroso, Jordi Alberch, Esther Pérez-Navarro. J Neurosci 2011
50
11

Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease.
Carmela Giampà, Stefano Patassini, Antonella Borreca, Daunia Laurenti, Fabrizia Marullo, Giorgio Bernardi, Frank S Menniti, Francesca R Fusco. Neurobiol Dis 2009
57
11


Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
502
11

Disturbance of real space navigation in moderately advanced but not in early Huntington's disease.
Veronika Majerová, Tomáš Kalinčík, Jan Laczó, Martin Vyhnálek, Jakub Hort, Martin Bojar, Evžen Růžička, Jan Roth. J Neurol Sci 2012
16
31

Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.
Paola Paoletti, Ingrid Vila, Maria Rifé, José Miguel Lizcano, Jordi Alberch, Silvia Ginés. J Neurosci 2008
95
11

Evidence for specific cognitive deficits in preclinical Huntington's disease.
A D Lawrence, J R Hodges, A E Rosser, A Kershaw, C ffrench-Constant, D C Rubinsztein, T W Robbins, B J Sahakian. Brain 1998
306
11

Brain-derived neurotrophic factor in neurodegenerative diseases.
Chiara Zuccato, Elena Cattaneo. Nat Rev Neurol 2009
617
11

Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Joshua L Plotkin, Michelle Day, Jayms D Peterson, Zhong Xie, Geraldine J Kress, Igor Rafalovich, Jyothisri Kondapalli, Tracy S Gertler, Marc Flajolet, Paul Greengard,[...]. Neuron 2014
122
11

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
11

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.
Edward C Stack, James K Kubilus, Karen Smith, Kerry Cormier, Steven J Del Signore, Emmanuel Guelin, Hoon Ryu, Steven M Hersch, Robert J Ferrante. J Comp Neurol 2005
185
11

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
Josep M Canals, José R Pineda, Jesús F Torres-Peraza, Miquel Bosch, Raquel Martín-Ibañez, M Teresa Muñoz, Guadalupe Mengod, Patrik Ernfors, Jordi Alberch. J Neurosci 2004
254
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.